Catalent stockholders approve deal with Novo Holdings
29/05/2024 14:14
May 29 (Reuters) - Catalent CTLT.N said on Wednesday
its stockholders have voted to approve its deal with Novo
Holdings, the parent company of Novo Nordisk NOVOb.CO .
In February, Novo Holdings had agreed to buy Catalent for
$16.5 billion.
(Reporting by Sriparna Roy in Bengaluru; Editing by Vijay
Kishore)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Catalent
See all newsBrief: Novo Holdings Completes Acquisition Of Catalent
Novo Nordisk rises as Catalent deal in US nears
Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say
Brief: Catalent And Novo Holdings Fulfill All Regulatory Closing Conditions For Pending Transaction
Brief: Novo Nordisk Says All Regulatory Closing Conditions Relating To Review Of Novo Holdings A/S's Pending Acquisition Of Catalent Have Been Fulfilled